As part of Open Journals’ initiatives, we create website for scholarly open access journals.
If you are responsible for this journal and would like to know more about how to use the editorial system, please visit our website at
https://ejournalplus.com or send us an email to info@ejournalplus.com
Novel 2-(3-(4-substitutedaryl)guanidine-1-yl)-4-phenyl-6-(thiophene-2-yl)pyrimidines (7) were synthesized by simple condensation between chalcones with therapeutic biguanide derivatives. The novel guanidinopyrimidine derivatives (7) were characterized by different spectral studies. Furthermore, subjected into ADMET prediction using pkSCM software and molecular docking studies against different kinds novel RNA proteins such as, spike (PDB ID: 6XC3), main protease (3CLpro - PDB ID: 6LU7), RNA-dependent RNA polymerase (RdRp – PDB ID: 6W9Q) and host protein ACE2 (PDB ID:1R42) spike protein and also the activities are compared with FDA approved few human trial drugs such as hydroxychloroquine (HQC), favipiravir and lopinavir.
(2020). Synthesis, Characterization, ADMET Prediction and Molecular Docking Studies Against COVID-19 Proteins of Novel 2-(3- (4-substituted aryl)guanidine-1-yl)-4- phenyl-6-(thiophene-2-yl)pyrimidines. European Journal of Molecular & Clinical Medicine, 7(3), 3930-3948.
Jayaraman Arikrishnan; Srinivasan Pazhamalai; Haridoss Manikandan; Selvarasu Sekar; Panneerselvam Kalaivani; Mannathusamy Gopalakrishnan. "Synthesis, Characterization, ADMET Prediction and Molecular Docking Studies Against COVID-19 Proteins of Novel 2-(3- (4-substituted aryl)guanidine-1-yl)-4- phenyl-6-(thiophene-2-yl)pyrimidines". European Journal of Molecular & Clinical Medicine, 7, 3, 2020, 3930-3948.
(2020). 'Synthesis, Characterization, ADMET Prediction and Molecular Docking Studies Against COVID-19 Proteins of Novel 2-(3- (4-substituted aryl)guanidine-1-yl)-4- phenyl-6-(thiophene-2-yl)pyrimidines', European Journal of Molecular & Clinical Medicine, 7(3), pp. 3930-3948.
Synthesis, Characterization, ADMET Prediction and Molecular Docking Studies Against COVID-19 Proteins of Novel 2-(3- (4-substituted aryl)guanidine-1-yl)-4- phenyl-6-(thiophene-2-yl)pyrimidines. European Journal of Molecular & Clinical Medicine, 2020; 7(3): 3930-3948.
